Ostrom QT, Cioffi G, Gittleman H et al (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro Oncol 21(Suppl 5):v1–v100. https://doi.org/10.1093/neuonc/noz150

Article  PubMed  PubMed Central  Google Scholar 

Euskirchen P, Peyre M (2018) Management of meningioma. Presse Med (Paris, France : 1983) 47(11–12 Pt 2):e245–e252. https://doi.org/10.1016/j.lpm.2018.05.016

Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brastianos PK, Galanis E, Butowski N, International Consortium on Meningiomas et al (2019) Advances in multidisciplinary therapy for meningiomas. Neuro-oncol 21(Suppl 1):18–31. https://doi.org/10.1093/neuonc/noy136

Article  CAS  Google Scholar 

McNeill KA (2016) Epidemiology of brain tumors. Neurol Clin 34(4):981–998. https://doi.org/10.1016/j.ncl.2016.06.014

Article  PubMed  Google Scholar 

Nakasu S, Fukami T, Jito J, Nozaki K (2009) Recurrence and regrowth of benign meningiomas. Brain Tumor Pathol 26(2):69–72. https://doi.org/10.1007/s10014-009-0251-2

Article  PubMed  Google Scholar 

Domingues PH, Sousa P, Otero Á et al (2014) Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype. Neuro Oncol 16(5):735–747. https://doi.org/10.1093/neuonc/not325

Article  PubMed  PubMed Central  Google Scholar 

Hwang WL, Marciscano AE, Niemierko A et al (2016) Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Neuro Oncol 18(6):863–872. https://doi.org/10.1093/neuonc/nov285

Article  PubMed  Google Scholar 

Nanda A, Bir SC, Maiti TK et al (2017) Relevance of Simpson grading system and recurrence-free survival after surgery for world health organization grade I meningioma. J Neurosurg 126(1):201–211. https://doi.org/10.3171/2016.1.JNS151842

Article  PubMed  Google Scholar 

Gallagher MJ, Jenkinson MD, Brodbelt AR et al (2016) WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant? Clin Neurol Neurosurg 141:117–121. https://doi.org/10.1016/j.clineuro.2016.01.006

Article  PubMed  Google Scholar 

Phonwijit L, Khawprapa C, Sitthinamsuwan B (2017) Progression-free survival and factors associated with postoperative recurrence in 126 patients with atypical intracranial meningioma. World Neurosurg 107:698–705. https://doi.org/10.1016/j.wneu.2017.08.057

Article  PubMed  Google Scholar 

Karimi S, Vyas MV, Gonen L, Tabasinejad R, Ostrom QT et al (2017) Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma. Neuro Oncol 19(11):1503–1510. https://doi.org/10.1093/neuonc/nox089

Article  PubMed  PubMed Central  CAS  Google Scholar 

Maier AD, Bartek J Jr, Eriksson F et al (2020) Clinical and histopathological predictors of outcome in malignant meningioma. Neurosurg Rev 43(2):643–653. https://doi.org/10.1007/s10143-019-01093-5

Article  PubMed  Google Scholar 

Kuranari Y, Tamura R, Tsuda N et al (2020) Prognostic Significance of preoperative neutrophil-to-lymphocyte ratio in patients with meningiomas. Front Oncol 10:592470. https://doi.org/10.3389/fonc.2020.592470

Article  PubMed  PubMed Central  Google Scholar 

Goldbrunner R, Stavrinou P, Jenkinson MD et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23(11):1821–1834. https://doi.org/10.1093/neuonc/noab150

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tien RD, Yang PJ, Chu PK (1991) “Dural tail sign”: a specific MR sign for meningioma? J Comput Assist Tomogr 15(1):64–66

Article  PubMed  CAS  Google Scholar 

Kwon SM, Kim JH, Yoo HJ et al (2020) Predictive factors for high-grade transformation in benign meningiomas. Clin Neurol Neurosurg 195:105897. https://doi.org/10.1016/j.clineuro.2020.105897

Article  PubMed  Google Scholar 

Rogers L, Barani I, Chamberlain M et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO Rev J Neurosurg 122(1):4–23. https://doi.org/10.3171/2014.7.JNS131644

Article  Google Scholar 

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1

Article  PubMed  Google Scholar 

Apra C, Peyre M, Kalamarides M (2018) Current treatment options for meningioma. Expert Rev Neurother 18(3):241–249. https://doi.org/10.1080/14737175.2018.1429920

Article  PubMed  CAS  Google Scholar 

Corniola MV, Lemée JM, Da Broi M et al (2019) Posterior fossa meningiomas: perioperative predictors of extent of resection, overall survival and progression-free survival. Acta Neurochir 161(5):1003–1011. https://doi.org/10.1007/s00701-019-03862-z

Article  PubMed  Google Scholar 

Durand A, Labrousse F, Jouvet A et al (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95(3):367–375. https://doi.org/10.1007/s11060-009-9934-0

Article  PubMed  Google Scholar 

Czernicki T (2020) Surgical management of intracranial meningiomas in the elderly: early and long-term outcomes. Clin Interv Aging 15:2439–2451. https://doi.org/10.2147/CIA.S283678

Article  PubMed  PubMed Central  Google Scholar 

Zima L, Baine MJ, Sleightholm R et al (2021) Pathologic characteristics associated with local recurrence of atypical meningiomas following surgical resection. J Clin Med Res 13(3):143–150. https://doi.org/10.14740/jocmr4444

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sughrue ME, Kane AJ, Shangari G et al (2010) The relevance of simpson grade I and II resection in modern neurosurgical treatment of world health organization grade I meningiomas. J Neurosurg 113(5):1029–1035. https://doi.org/10.3171/2010.3.JNS091971

Article  PubMed  Google Scholar 

Schipmann S, Schwake M, Sporns PB et al (2018) Is the simpson grading system applicable to estimate the risk of tumor progression after microsurgery for recurrent intracranial meningioma? World Neurosurg 119:e589–e597. https://doi.org/10.1016/j.wneu.2018.07.215

Article  PubMed  Google Scholar 

Aizer AA, Abedalthagafi M, Bi WL, Horvath MC et al (2016) A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma. Neuro-Oncol 18(2):269–274. https://doi.org/10.1093/neuonc/nov177

Article  PubMed  CAS  Google Scholar 

Youngblood MW, Miyagishima DF, Jin L et al (2021) Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol 23(5):783–794. https://doi.org/10.1093/neuonc/noaa226

Article  PubMed  CAS  Google Scholar 

Salles D, Santino SF, Malinverni ACM, Stávale JN (2021) Meningiomas: A review of general, histopathological, clinical and molecular characteristics. Pathol Res Pract 223:153476. https://doi.org/10.1016/j.prp.2021.153476

Article  PubMed  CAS  Google Scholar 

Spille DC, Heß K, Sauerland C, Sanai N et al (2016) Brain invasion in meningiomas: incidence and correlations with clinical variables and prognosis. World neurosurgery 93:346–354. https://doi.org/10.1016/j.wneu.2016.06.055

Article  PubMed  Google Scholar